Clinical Trial Update: A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This document updates a Phase 2 clinical study of LY3541860 in adults with moderately to severely active rheumatoid arthritis, noting that the trial is ongoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LY3541860

Snippet

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING